Exact Sciences
EXAS
#1992
Rank
S$10.13 B
Marketcap
$54.54
Share price
-1.61%
Change (1 day)
-36.57%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -S$1.38 Billion

According to Exact Sciences's latest financial reports the company's current earnings are S$2.75 Billion. a decrease over its 2023 earnings that were of -S$0.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -S$1.34 Billion435.08%
2023 -S$0.25 Billion-69.28%
2022 -S$0.82 Billion-25.55%
2021 -S$1.09 Billion1.68%
2020 -S$1.08 Billion271.17%
2019 -S$0.29 Billion58.99%
2018 -S$0.19 Billion20.89%
2017 -S$0.16 Billion-30.95%
2016 -S$0.22 Billion5.09%
2015 -S$0.21 Billion57.24%
2014 -S$0.14 Billion116.53%
2013 -S$60.74 Million
2011 -S$37.82 Million143.73%
2010 -S$15.52 Million27.85%
2009 -S$12.14 Million0.27%
2008 -S$12.11 Million-20.95%
2007 -S$15.31 Million-13.53%
2006 -S$17.71 Million-10.07%
2005 -S$19.69 Million-21.81%
2004 -S$25.19 Million-33.44%
2003 -S$37.83 Million-6.51%
2002 -S$40.47 Million17.95%
2001 -S$34.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$0.16 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
S$86.42 M-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$33.77 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$45.87 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.41 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France